In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Intoxicating idea: Jose Cuervo to convert agave into straws
In Tequila, Mexico, margarita mainstay Jose Cuervo has launched a project to convert agave byproduct into biodegradable straws.
The straws were developed in partnership with...
Corpse to compost: The next funeral trend?
In Washington, a human composting facility is set to begin operations in the Seattle area in spring 2021.
Recompose’s process involves sealing a body into...
Airline trials biscotti coffee cups
In New Zealand, a local airline will trial the use of edible coffee cups made from biscotti in a bid to reduce the reduce...